The Clock That Never Stops: Understanding Patent Term Adjustment and Extension in India, the US, and Europe

#ai #webdev #programming #productivity

There is something almost poetic about the way patents work. An inventor spends years; developing something the world has never seen before. The law rewards that effort with a patent: a twenty-year window during which the inventor alone has the right to make, use, sell, or license the invention.

Twenty years sounds generous. But here is the part that most people outside the patent world never quite appreciate: that twenty-year clock starts ticking from the very day the patent application is filed, not the day the patent is granted. And in a world where regulatory approvals, examination backlogs, and procedural delays routinely eat up years of that window, inventors often find themselves holding a patent with only a fraction of its commercial life left.

This is the problem that Patent Term Adjustment (PTA) and Patent Term Extension (PTE) were designed to solve. However, it depends enormously on which country you are standing in.

India’s Approach: A Significant Silence

The Patents Act, 1970, India’s principal patent legislation, as amended most significantly in 2005 to align with the TRIPS Agreement, grants a patent term of twenty years from the date of filing under Section 53. But when you look for provisions that compensate an inventor for delays caused by the Patent Office itself, or for the regulatory maze that pharmaceutical inventors must navigate before their drug reaches the market, you find a conspicuous gap. India does not have a formal PTA mechanism.

There is no statutory provision under which a patent applicant can seek additional patent life to compensate for delays caused by the Indian Patent Office during examination. Similarly, there is no PTE framework for pharmaceutical or agrochemical products that must undergo regulatory approval before commercialisation.

The Indian system operates on a straightforward, unadjusted twenty-year term, and that is the end of the matter: at least for now.

This is not to say that India is entirely insensitive to the problem. The Office of the Controller General of Patents, Designs and Trade Marks (CGPDTM) has, in recent years, undertaken significant efforts to reduce examination pendency.

Get More Info : Intellectual Property Law Firm India

Website : https://kankrishme.com/